Early Initiation of Palliative Care Improves 1-Year Survival

Share this content:
Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation.
Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation.

Early initiation of concurrent palliative oncology care improved 1-year survival compared with delayed initiation, a new study published online early in the Journal of Clinical Oncology has shown.

Although randomized controlled trials have supported integrated oncology and palliative care, the optimal timing of initiation of that care has not been determined.

Therefore, researchers sought to evaluate the effect of early versus delayed palliative care on 1-year survival, quality of life, symptom impact, mood, and resource use among patients with cancer at a National Cancer Institute cancer center, a Veteran Affair Medical Center, and community outreach clinics.

RELATED: Data Collection Improves Patient Outcomes in Hospice, Palliative Care

For the study, participants were randomly assigned to receive an in-person palliative care consultation, structured palliative care telehealth nurse coaching sessions, and monthly follow-up either early after being enrolled or 3 months afterwards.

Results showed that overall quality of life, symptom impact, and mood were not statistically significantly different after enrollment or before death.

Researchers found that the 1-year survival rates were 63% and 48% in the early and delayed groups, respectively (P = 0.038). Resource use was also similar between the two groups.

Reference

  1. Bakitas MA, Tosteson TD, Zhigang L, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015. [Epub ahead of print]. doi: 10.1200/JCO.2014.58.6362.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs